i do think the people who do best with the actual pharmacetical manufacture or "mix" if you like is where the value is - that and delivery technologies i guess
brand also will be important but in australias case the relationships with the prescribing and potential doctors is critcial - that is where AC8 and MDC are well ahead of competition from what I can see
the actual source products, and growing, will be agricultural business in my mind, hig capex, low margins, that is why I am not so much a fan of those names that are focused on growing
That is why i like AC8 and MDC over CAN and then all the other listed names who it would seem are spending either too much on growing facilities or PR !
- Forums
- ASX - By Stock
- Ann: Medlab's Progress to Date on Cannabis Spray (NanaBis)
i do think the people who do best with the actual pharmacetical...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
MDC (ASX) Chart |
Day chart unavailable
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online